Search - tctmd.com

Displaying 81 - 100 of 654

Sort: Relevancy | Date

Presentation TCT 2024

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Presenter: David Wood

October 30, 2024

Presentation TCT 2024

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

Presenter: Pierre Elias

October 30, 2024

Presentation TCT 2024

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Patient Perspectives and Shared Decision-Making in Younger Patients Requiring AS Therapy

Presenter: Megan Coylewright

October 30, 2024

Presentation TCT 2024

Surgical Valve Selection in Younger Patients with AS: Mechanical, Bioprosthetic, or Ross?

Presenter: Katherine Harrington

October 30, 2024

Presentation TCT 2024

The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps

Presenter: Harold Dauerman

October 30, 2024

Presentation TCT 2024

Building Partnerships: How RECHARGE is Engaging Patients and Stakeholders

Presenter: Ruth Masterson Creber

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

A Novel Doppler-Based Technology for the Non-Invasive Analysis of Cardiac Hemodynamics (Diagnics)

Presenter: Zahra K. Motamed

October 28, 2024

Presentation TCT 2024

Pulmonary Artery Pulsatility Index in Patients Undergoing Transcatheter Tricuspid Valve Interventions

Presenter: Guillaume Bonnet

October 28, 2024

Presentation TCT 2024

Predicting Outcomes in Patients Undergoing TTVr for Severe TR: Role of Right Ventricular Free Wall Longitudinal Strain-Derived Pulmonary-Arterial Coupling

Presenter: Jennifer von Stein

October 28, 2024

Presentation TCT 2024

Regurgitant Fraction Quantified by Liver Mapping Analysis Using Cardiac Magnetic Resonance Predict Outcomes in a Large Cohort of All-Comers Patients with Chronic Tricuspid Regurgitation

Presenter: Davide Margonato

October 28, 2024

Presentation Interventional Complications 2024

How to Build a High-Risk Program in a Challenging Environment (Difficult Admin, Partners, Surgeons, Geographic Location)

Presenter: Rhian Davies

August 02, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Access Disparities Affecting Appropriate AS Therapy

Presenter: David A. Wood

June 07, 2024

Presentation NY Valves 2024

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Presenter: Brian R. Lindman

June 07, 2024

Presentation NY Valves 2024

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Presenter: Michael J. Reardon

June 07, 2024

Presentation NY Valves 2024

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

Presenter: Robert L. Smith, Megan Coylewright

June 07, 2024

Presentation NY Valves 2024

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Presenter: Jonathan Michel

June 07, 2024

Advertisement

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Patient Perspectives and Shared Decision-Making in Younger Patients Requiring AS Therapy

Surgical Valve Selection in Younger Patients with AS: Mechanical, Bioprosthetic, or Ross?

The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps

Building Partnerships: How RECHARGE is Engaging Patients and Stakeholders

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

A Novel Doppler-Based Technology for the Non-Invasive Analysis of Cardiac Hemodynamics (Diagnics)

Pulmonary Artery Pulsatility Index in Patients Undergoing Transcatheter Tricuspid Valve Interventions

Predicting Outcomes in Patients Undergoing TTVr for Severe TR: Role of Right Ventricular Free Wall Longitudinal Strain-Derived Pulmonary-Arterial Coupling

Regurgitant Fraction Quantified by Liver Mapping Analysis Using Cardiac Magnetic Resonance Predict Outcomes in a Large Cohort of All-Comers Patients with Chronic Tricuspid Regurgitation

How to Build a High-Risk Program in a Challenging Environment (Difficult Admin, Partners, Surgeons, Geographic Location)

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Access Disparities Affecting Appropriate AS Therapy

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content